|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3211082 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17153724.4 |
| Date of filing the European patent application | 2012-04-25 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation | 2021-05-10 |
| (30) | Number | Date | Country code |
| 201161478767 P | 2011-04-25 | US | |
| 201161565779 P | 2011-12-01 | US |
| (72) |
BHAT, Balkrishen, US
|
| (73) |
Sanofi,
54, rue La Boétie, 75008 Paris,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Mikro RNR junginiai ir būdai miR-21 aktyvumui moduliuoti |
| MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 15 | 289.00 EUR |
| 2027-04-25 |